483 North China Pharmaceutical Huasheng Aug 2018

483 North China Pharmaceutical Huasheng Aug 2018

Niketa Patel FDA$119.00 - Available Now

FDA investigators audited the North China Pharmaceutical Huasheng - Shijiazhuang, China facility and issued inspectional observations (via FDA 483) on 10 Aug 2018.

Product details

  • Category: Human Drugs / Animal Drugs & Feeds
  • Inspection end: 10 Aug 2018
  • Location: Shijiazhuang, China
  • FEI: 3003001488
Add To Cart